Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
| Buyback Record Date | January 14, 2022 |
| Buyback Open Date | February 3, 2022 |
| Buyback Closing Date | February 16, 2022 |
| Issue Size (Shares) | 0.11 Crores |
| Issue Size (Amount) | ₹285.60 Crores |
| Buyback Price | ₹2550 per Share |
May 3, 2024 9:11:48 AM
The Ajanta Pharma stock jumped 13.38 per cent to hit a high of Rs 2,531.95 on BSE. A few target prices on the stock are in the range of Rs 2,560-2,613, suggesting limited upside ahead.
Published by : Business Today on MSNMay 2, 2024 5:20:00 PM
Ajanta Pharma on Thursday announced a Rs 285 crore buyback of up to 10.28 lakh shares through a tender offer at a price of Rs 2,770 � a premium of 24% --- against Thursdays closing price of Rs 2,233.
Published by : IndiatimesMay 2, 2024 3:40:12 PM
In an exchange filing, the pharma company informed that it has generated a robust cash flow of Rs 812 crore with an impressive cash conversion ratio of 69 per cent. Given this strong financial ...
Published by : ET Now on MSNMay 2, 2024 2:39:42 PM
The Mumbai-based pharma major's revenue came in at Rs 1,054.08 crore, up 20 percent from Rs 881.84 crore a year back.
Published by : moneycontrol.com on MSNMay 5, 2024 2:00:00 PM
Ajanta Pharma Ltd shares gained 8.01% in 1 week after it reported healthy Q4 results and buyback plan. Ajanta Pharma Ltd announced an equity dividend amounting to Rs 51.00 per share in last 1-year, ...
Published by : GoodreturnsMay 2, 2024 6:24:00 PM
Mumbai Based, Ajanta Pharma on Thursday reported a consolidated net profit of Rs 202.72 crore for the January-March quarter, marking a significant surge of 66% compared to the same period last year ...
Published by : GoodreturnsMay 1, 2024 3:04:00 PM
We are amidst the earnings season and it is usually at this time that India Inc. also decides on corporate actions relative to their financial health. Likewise, midcap pharma company Ajanta Pharma ...
Published by : Zee BusinessMay 3, 2024 8:26:00 AM
Friday's gains come after�the company's board approved the buyback of its shares and reported its March quarter earnings. This is the fourth buyback of equity shares for Ajanta Pharma since 2020.
Published by : cnbctv18May 3, 2024 7:57:00 AM
The board has fixed May 30 as the record date to determine the entitlement and names of shareholders, who will be entitled to participate in the proposed offer for buyback.
Published by : Zee BusinessMay 2, 2024 5:36:00 PM
The company anticipates the fastest growth to come from its dermatology portfolio, followed by ophthalmology and cardiology.
Published by : moneycontrol.comMay 2, 2024 6:05:00 PM
Ajanta Pharma on Thursday said its consolidated net profit increased 66 per cent to Rs 203 crore in the March quarter, aided by robust sales across domestic and international markets.
Published by : Business StandardMay 3, 2024 9:41:00 AM
Ajanta Pharma recorded a 66 per cent on year spike in consolidated net profit to ?202.72 crore for the January-March period.
Published by : Hindustan TimesRead Ajanta Pharma Buyback current news. Find Ajanta Pharma Buyback subscription news, Buyback analysis, broker reviews, allotment news, and listing date. Get the Ajanta Pharma Limited Buyback grey market premium and Ajanta Pharma Buyback expected listing price.
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
